TickerFacts.

Northwest Biotherapeutics Inc (NWBO): Capital Expenditures

Annual figures by period end, from SEC filings.

$1.50M
Year ended 2025-12-31
$1.43M
Trailing 12 months to 2026-06-30
2010-12-31: $41.0K2011-12-31: $49.0K2012-12-31: $31.0K2013-12-31: -$1.0K2019-12-31: $171.0K2024-12-31: $1.01M2025-12-31: $1.50M$1.50M
2010-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$1.50M+48.3%2026-04-15, From 2025-01-01
2024-12-31$1.01Mn/a2026-04-15, From 2024-01-01
No annual figure between 2019-12-31 and 2024-12-31.
2019-12-31$171.0Kn/a2020-03-16, From 2019-01-01
No annual figure between 2013-12-31 and 2019-12-31.
2013-12-31-$1.0Kn/m2014-04-01, From 2013-01-01
2012-12-31$31.0K-36.7%2014-04-01, From 2012-01-01
2011-12-31$49.0K+19.5%2013-04-08, From 2011-01-01
2010-12-31$41.0Kn/a2012-04-13, From 2010-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Northwest Biotherapeutics Inc (NWBO)2025-12-31$1.50M+48.3%
Cannapharmarx, Inc. (CPMD)2025-12-31$5.5Kn/a
NRX Pharmaceuticals, Inc. (NRXP)2024-12-31$0-100.0%
IGC Pharma, Inc. (IGC)2025-03-31$112.0K-18.8%
Longeveron Inc. (LGVN)2025-12-31$245.0K-62.6%
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31$88.0K-67.2%
China SXT Pharmaceuticals, Inc. (SXTC)2025-03-31$2.0K-71.4%
Bespoke Extracts, Inc. (BSPK)2024-12-31$600.0Kn/a
Dare Bioscience, Inc. (DARE)2025-12-31$385.3K-32.8%

Compare NWBO, CPMD, NRXP, IGC side by side · Screen every company in Pharmaceutical Preparations ↗